CCT3 drives Sorafenib resistance by inhibiting TFRC-mediated iron uptake in HCC
Zhu, H.; Liu, Q.; Meng, Q.; Zhang, L.; Lan, J.; Zhu, D.; Chen, Y.; Aishan, N.; Ouyang, X.; Zhang, S.; Jin, L.; Xiao, L.; Wang, L.; Li, L.; Ji, F.
Show abstract
Sorafenib is commonly utilized in the management of advanced hepatocellular carcinoma (HCC). However, its efficacy in extending patients survival is hindered by the development of drug resistance. By employing protein posttranslational modification (PTM) omics, including acetylome, phosphoproteome, and ubiquitinome, in conjunction with genome-wide CRISPR/Cas9 knockout library screening, we have successfully identified chaperonin containing TCP1 subunit 3 (CCT3) as a key factor contributing to Sorafenib resistance. Furthermore, we observed a reduction in the ubiquitination of CCT3 at lysine 21 (K21) subsequent to Sorafenib treatment. This study provides evidence that CCT3 hinders the recycling of transferrin receptor protein 1 (TFRC) by interacting with alpha-actinin-4 (ACTN4), which is influenced by K6-linked ubiquitination on K21. Depleting CCT3 increased the susceptibility of cells to Sorafenib-induced ferroptosis, while reintroducing CCT3 through transfection restored resistance to ferroptosis. Additionally, impairing ACTN4 or TFRC depletion compromised CCT3s ability to inhibit Sorafenib-induced ferroptosis. In summary, targeting CCT3 presents a potential strategy for overcoming Sorafenib resistance in HCC.
Matching journals
The top 14 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Targeting SLC7A11-mediated cysteine metabolism for the treatment of trastuzumab resistant HER2 positive breast cancer 95%
- Spatial modeling reveals nuclear phosphorylation and subcellular shuttling of YAP upon drug-induced liver injury 94%
- Elevated Ubiquitin Phosphorylation by PINK1 Contributes to Proteasomal Impairment and Promotes Neurodegeneration 94%
Similar papers in this journal
- Epidermal Growth Factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium 95%
- Oncogenic KEAP1 mutations activate TRAF2-NFκB signaling to prevent apoptosis in lung cancer cells 94%
- Amino acid restriction sensitizes lung cancer cells toferroptosis via GCN2-dependent activation of the integratedstress response 94%
Similar papers in this journal
- The E3 ligase NEDD4L prevents colorectal cancer liver metastasis via degradation of PRMT5 to inhibit the AKT/mTOR signaling pathway 94%
- Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer. 93%
- Massively parallel screening of TIR-derived peptides reveals vast TLR-targeting immunomodulatory peptides 93%
Similar papers in this journal
- Ubiquitination is a novel post-translational modification of VMP1 in autophagy of human tumor cells 94%
- TANK binding kinase 1 promotes BACH1 degradation through both phosphorylation-dependent and -independent mechanisms without relying on heme and FBXO22 93%
- A proteomic study of the dual oncogenic and tumor- suppressive roles of SIRT3 in lung and breast cancer cell lines 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.